Recent evidence suggests that pregnant women are at a higher risk of morbidity and mortality from COVID-19, compared with age-matched women who are not pregnant. Yet the historical and systematic exclusion of pregnant women from research continues in the context of the COVID-19 pandemic, resulting in a lack of evidence for this population. How can pregnant women be ethically and safely included in research and what part should researchers play in this? What role is there for community engagement to reconcile cultural norms and beliefs with the ethical and clinical rationale for research during pregnancy? And how do current governance mechanisms and regulation help or hinder the inclusion of pregnant women in research?
PHEPREN and the Global Forum on Bioethics in Research are pleased to announce three virtual seminars. The seminars will examine past GFBR themes and recommendations, in the context of the current COVID-19 research response: ethics of research in pregnancy; the ethics of data sharing in health research and the ethics of adaptive trial designs. We will explore how research practice and policy has progressed since the topics were discussed at GFBR, and what changes are needed in light of the current pandemic.
Chair: Maggie Little, Georgetown University, USA
Marian Knight, Nuffield Department of Population Health, University of Oxford, UK @Marianfknight
Loulou Kobeissi, Scientist, Universal Health Coverage – Life Course Division (UHC/LC)/ SRH Integration in Health Systems (SHS); Department of Sexual and Reproductive Health and Research (SRH), World Health Organization (WHO)
Sonali Kochhar, Global Healthcare Consulting, India; Department of Global Health, University of Washington, Seattle, USA
Further details available at https://epidemicethics.tghn.org/seminars/.